dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Fernandez-Fernandez, Beatriz |
dc.contributor.author | Sarafidis, Pantelis |
dc.contributor.author | Soler, María José |
dc.contributor.author | Ortiz Arduan, Alberto |
dc.date.accessioned | 2023-09-01T07:35:09Z |
dc.date.available | 2023-09-01T07:35:09Z |
dc.date.issued | 2023-08 |
dc.identifier.citation | Fernández-Fernandez B, Sarafidis P, Soler MJ, Ortiz A. EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors. Clin Kidney J. 2023 Aug;16(8):1187–98. |
dc.identifier.issn | 2048-8513 |
dc.identifier.uri | https://hdl.handle.net/11351/10204 |
dc.description | Malaltia renal crònica; Normoalbuminúria; Prevenció primària |
dc.description.sponsorship | FIS/Fondos FEDER (PI20/00744, PI19/00588, PI19/00815, PI21/01292, PI21/00251), ERA-PerMed-JTC2018 (KIDNEY ATTACK AC18/00064, ISCIII-RETIC REDinREN RD016/0009), ERA-PerMed-JTC 2022 (ONAKI-ICI AC22/00029) Sociedad Española de Nefrología, Sociedad Madrileña de Nefrología (SOMANE), FRIAT, Comunidad de Madrid en Biomedicina B2017/BMD-3686 CIFRA2-CM. Instituto de Salud Carlos III (ISCIII) RICORS program to RICORS2040 (RD21/0005/0001, RD21/0005/0016) funded by European Union—NextGenerationEU, Mecanismo para la Recuperación y la Resiliencia (MRR), SPACKDcPMP21/00109, FEDER funds, and Marató TV3 2020 421/C/2020, Marató TV3 2021 215/C/2021. |
dc.language.iso | eng |
dc.publisher | Oxford University Press |
dc.relation.ispartofseries | Clinical Kidney Journal;16(8) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Insuficiència renal crònica - Tractament |
dc.subject | Glucosúria |
dc.subject.mesh | Renal Insufficiency, Chronic |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Sodium-Glucose Transporter 2 Inhibitors |
dc.subject.mesh | /therapeutic use |
dc.title | EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1093/ckj/sfad082 |
dc.subject.decs | insuficiencia renal crónica |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | inhibidores del cotransportador de sodio-glucosa 2 |
dc.subject.decs | /uso terapéutico |
dc.relation.publishversion | https://doi.org/10.1093/ckj/sfad082 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Fernández-Fernandez B, Ortiz A] Department of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain. RICORS2040, Madrid, Spain. Departamento de Medicina, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain. GEENDIAB, Sociedad Española de Nefrología, Spain. [Sarafidis P] Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece. [Soler MJ] RICORS2040, Madrid, Spain. GEENDIAB, Sociedad Española de Nefrología, Spain. Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain |
dc.identifier.pmid | 37529652 |
dc.identifier.wos | 001018798700001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |